Bora CDMO Bora CDMO

X

Find the latest Drugs in Development and Pipeline Prospector News of NeRRe Therapeutics.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
NeRRe Therapeutics
unitedkingdom_new Flag
Country
Country
United Kingdom
Address
Address
Stevenage Bioscience Catalyst Incubator Building, Gunnels Wood Road, Stevenage, Herts, SG1 2FX
Telephone
Telephone
+44 (0) 1438 906 960
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

New funds to evaluate orvepitant as a treatment for the disabling chronic cough associated with idiopathic pulmonary fibrosis (IPF). The chronic cough can markedly reduce quality of life, is often refractory to medical therapy and there are no approved treatments for it.


Lead Product(s): Orvepitant Maleate

Therapeutic Area: Pulmonary/Respiratory Diseases Product Name: GW823296X

Highest Development Status: Phase IProduct Type: Small molecule

Partner/Sponsor/Collaborator: Columbus Venture Partners

Deal Size: $27.8 million Upfront Cash: Undisclosed

Deal Type: Series B Financing July 07, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY